| Name | (±)-Lisofylline |
|---|---|
| Synonyms |
(+/-)-LISOFYLLINE
HYDROXY PENTOXIFYLLINE (+/-)-1-(5-HYDROXYHEXYL)-3,7-DIMETHYLXANTHINE (±)-Lisofylline, Anti-inflammatory agent 1-(5-Hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione 5-Hydroxy pentoxifylline Lisofylline (racemic) 1-(5-hydroxyhexyl)-3,7-dimethylxanthine, pentoxyfylline metabolite 2/(±)-Lisofylline 1-[(R)-5-Hydroxyhexyl]theobromine (±)-Lisofylline, 10 mM in DMSO Pentoxifylline Impurity 16 ((+/-)-Lisofylline) 1H-Purine-2,6-dione, 3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl phosphatidic acid,pro-inflammatory cytokines,(±)-Lisofylline,inhibit,(±)Lisofylline,(±) Lisofylline,Inhibitor,free fatty acids,(±)-Lisophylline,Type 1 diabetes R-1-(5-Hydroxyhexyl)-3,7-dimethylxanthine (R)-3,7-Dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6-dione 1-(5-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione 1-[(5R)-5-Hydroxyhexyl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione Penthydroxifillyne Hydroxy Pentoxifylline (rac-Lisofylline) Hydroxy PentoxifyllineQ: What is Hydroxy Pentoxifylline Q: What is the CAS Number of Hydroxy Pentoxifylline Q: What is the storage condition of Hydroxy Pentoxifylline Q: What e the applications of Hydroxy Pentoxifylline 1-(5-hydroxyhexyl)-3,7-dimethylxanthine, pentoxyfylline metabolite 2 UNII:R99EE080JS 3,7-Dihydro-1-(5-hydroxyhexyl)-3,7-diMethyl ProTec pentoxyfylline metabolite 2 1-(5-Hydroxyhexyl)-3,7-dimethyl-1,2,3,6-tetrahydro-7H-purine-2,6-dione LISOFYLLINE CT 1501R |
| Description | (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 511.2±56.0 °C at 760 mmHg |
| Melting Point | 123-125ºC |
| Molecular Formula | C13H20N4O3 |
| Molecular Weight | 280.323 |
| Flash Point | 263.0±31.8 °C |
| Exact Mass | 280.153534 |
| PSA | 82.05000 |
| LogP | 0.34 |
| Appearance | solid | white |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.621 |
| Storage condition | Refrigerator |
| Water Solubility | DMSO: soluble |
| RIDADR | NONH for all modes of transport |
|---|---|
| WGK Germany | 3 |
|
~91%
6493-06-7 |
| Literature: Kala, Elzbieta P.; Wojcik, Tomasz Acta Poloniae Pharmaceutica - Drug Research, 2007 , vol. 64, # 2 p. 109 - 113 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |